Acclaimed R&B singer D’Angelo passed away on October 14 at age 51 after a personal fight with pancreatic cancer.
“The brilliant light of our family has dimmed his light for us in this life,” his relatives confirmed. “After a lengthy and brave battle with the disease, we are heartbroken to declare that Michael D’Angelo Archer, known to his fans around the globe as D’Angelo, has been called home.”
D’Angelo made a lasting impact on music with his innovative neo-soul sound and collaborations with high-profile artists.
He released his first record, “Brown Sugar,” in 1995 to immediate acclaim. The record reached the fourth spot on Billboard’s Top R&B Albums chart, earned platinum status soon after, and received several Grammy nominations.
However, it was his sophomore release, “Voodoo,” in the year 2000 that boosted his artistic journey into the stratosphere. The album premiered at the top spot on each of the R&B charts and the main album chart. He won two Grammy Awards: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”
The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a hesitant one, in the cultural zeitgeist. The personal depiction featured the singer, famously bare to his waist, singing straight into the lens.
D’Angelo retreated from the public eye after releasing Voodoo and publicly struggled with drugs and alcohol. In 2005, he was part of a serious vehicle accident that left him in grave health.
More than a decade later, his third and final album, “Black Messiah” (2014), reaffirmed his enduring appeal with a further No. 1 debut on the R&B chart and a Grammy for Top R&B Record.
Once more, in his own mysterious fashion, D’Angelo made only a few public appearances in the following years.
The singer was announced as a headliner for the 2025 Roots Picnic festival, but his performance was canceled, due to an “unexpected health issue.”
Even though details are sparse about D’Angelo’s health in the months before his death, he had reportedly been hospitalized for an extended period and in palliative care for a fortnight.
D’Angelo’s demise is a stark reminder of the devastating effects of pancreatic cancer, one of the most deadly and hardest to prevent types of the illness, on a gifted artist whose life was cut short.
“We are grieved that he can only leave cherished moments with his family, but we are forever thankful for the heritage of extraordinarily moving songs he leaves behind,” his family said.
Pancreatic cancer affects the digestive organ, a small organ that produces insulin and is vital in breaking down food, among other functions. The size and location of the pancreas in the human system make it more difficult to identify malignancy.
Although this cancer accounts for only approximately three percent of malignancy cases each year in the U.S., it is responsible for 7% of malignancy fatalities.
Almost 70,000 individuals will be diagnosed with pancreatic cancer and roughly fifty-two thousand will succumb to the illness in the year 2025.
“This malignancy is one of the deadliest cancers, with an aggressive tumor and poor prognosis. We have few and poor therapies, and a smaller window to make a meaningful impact on the lives of patients,” said a cancer specialist.
Because pancreatic cancer seldom produces early symptoms, it’s frequently diagnosed only after the disease is advanced. Even when a patient has symptoms they are usually vague and may be confused with a number of everyday ailments.
“As of yet, there is no good way to identify pancreatic cancer in the initial phases, except for paying attention to physical changes and speaking with your physician if there are unfamiliar signs,” explained a medical director.
Frequent indicators of pancreatic cancer encompass:
At age 51, D’Angelo’s demise is an outlier, as this malignancy is most common in individuals in the sixty-five to seventy-five range. However, numerous malignancies, such as this type, have become increasingly prevalent in younger people.
“This disease diagnosed prior to fifty is considered rare, yet concerningly, clinicians are beginning to see a rising count of younger patients suffering from this disease,” said a specialist.
In the absence of effective detection methods for this malignancy, professionals emphasized the significance of understanding your family’s cancer history. Certain contributing elements, such as smoking and excess weight also have an influence in the development of this disease.
Black individuals have the highest incidence of pancreatic cancer in the U.S. and are more prone to be found to have inoperable cancer.
“The first step toward lowering one’s risk of pancreatic cancer is assessing individual susceptibility. People should examine their genetic background, genetic background, and medical conditions, such as blood sugar disease, long-term pancreas inflammation, or obesity that may raise their susceptibility,” said a specialist.
Inherited genetic risk factors are associated with as much as ten percent of all pancreatic cancer instances. If someone in your household has had pancreatic cancer, you may want to consider DNA analysis.
“For individuals with a family history of this condition or those carrying elevated risk DNA changes, checking may involve sophisticated scans such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to detect early changes in the organ,” he clarified.
For those looking to lower their chance, habit adjustments may make a difference. The most effective step you can take to lower your risk of this disease is to quit smoking, and if you are a non-smoker, stay away altogether.
Excessive alcohol consumption is associated with pancreatitis, a contributing element for this malignancy, so limiting or abstaining from alcohol may help lower your chance.
Managing your weight or shedding pounds may also help reduce your risk. People with excess weight are 20% more likely to get this disease. Pancreatic cancer also is more frequent in people with diabetes, and reducing weight can also reduce the chance of adult-onset diabetes.
In spite of this disease’s poor prognosis, there is reason for optimism.
“We are making progress with treatments and more recent combination chemotherapy. There are emerging precision medicines that already are showing results,” said a expert.
For many people, however, awareness about this rare but {dev
Elara Vance is a tech journalist with over a decade of experience covering emerging technologies and consumer electronics.